Sirtuin 1 emerges as the molecular switch linking cellular senescence to heart failure
A new review argues that the longevity enzyme sirtuin 1 sits at the molecular crossroads between cellular senescence and heart ...
A new review argues that the longevity enzyme sirtuin 1 sits at the molecular crossroads between cellular senescence and heart ...
Two drug classes born as diabetes therapies are quietly reshaping cardiovascular medicine, and a group of European stroke specialists argues ...
A new control theory framework published in Aging redefines aging as a progressive loss of safe controllability and proposes safety-first ...
A randomized clinical trial shows that four weeks of canagliflozin treatment significantly reduces pancreatic beta-cell responsiveness to glucose in insulin-dysregulated ...
A new review explains why diabetes doubles to quadruples urinary tract infection risk, how high blood sugar and bacterial virulence ...
A new viewpoint in eClinicalMedicine argues that cardiorenal trials should routinely report absolute risk reduction and number needed to treat ...
A real-world study of 9000 patients with type 2 diabetes in China used cluster analysis to identify three clinical phenotypes ...
A four-year cohort study found that diabetes care during the COVID-19 pandemic shifted durably toward telemedicine and intensified drug therapy ...
A new study links SGLT2 inhibitor therapy with reduced circulating activin A, improved right-heart function, and modulation of BMP/activin signaling ...
A Swedish population-based study of adults aged 75 and older with type 2 diabetes finds that advanced chronic kidney disease ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine